Textbook of Personalized Medicine - Second Edition [2015]

xix PET Imaging for Determining Response to Chemotherapy ................. 230 Tissue Systems Biology Approach to Personalized M ...

xx Testing Microsatellite-Instability for Response to Chemotherapy ....... 265 Pharmacogenetics of Cancer Chemotherapy ......... ...

xxi 11 Personalized Management of Infectious Diseases ................................ 383 Introduction ........................ ...

xxii Personalized Management of Huntington’s Disease ................................. 424 Genomics of Huntington Disease ...... ...

xxiii Personalized Management of Sleep Disorders ......................................... 454 Personalized Therapy of Insomnia ...

xxiv Project euHeart for Personalized Management of Heart Disease ......... 506 Concluding Remarks on Personalized Management of ...

xxv Personalizing New Therapies for CF .................................................... 548 Gene Therapy and Pharmacogenomic ...

xxvi Personalized Management of Osteoporosis .............................................. 572 Personalized Management of Renal ...

xxvii Ignite Institute ....................................................................................... 617 Indiana Unive ...

xxviii Advantages of Personalized Medicine ...................................................... 651 Limitations of Personalize ...

xxix Pharmacogenetics to Reduce the Cost Incurred by Adverse Drug Reactions .................................................... ...

...

xxxi List of Figures Fig. 1.1 Relation of personalized medicine to other technologies .............. 20 Fig. 1.2 Relation of sys ...

xxxii Fig. 9.1 Role RNAi in development of personalized medicine .................. 196 Fig. 10.1 Relationships of technologies ...

xxxiii Fig. 23.1 Cost of sequencing per genome (DNA sequencing costs: data from the NHGRI Genome Sequencing Program. http://www. ...

...

xxxv List of Tables Table 1.1 Selected terms relevant to the concept of personalized medicine .................................. ...

xxxvi Table 5.1 Role of pharmacogenomics in variable therapy targets .............. 150 Table 5.2 Pharmacogenetic vs. pharmacoge ...

xxxvii Table 20.4 Advantages of personalized medicine for the biopharmaceutical industry ....................................... ...

...